60 Degrees Pharmaceuticals (SXTP) Assets Average (2023 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Assets Average of $6.1 million for Q1 2026, up 3.34% year-over-year from $5.9 million in Q1 2025, and up 0.61% quarter-over-quarter from $6.0 million in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Assets Average (2023 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Assets Average for 4 consecutive years, with $6.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 3.34% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (up 3.34% YoY), while the FY2025 annual figure was $5.6 million, down 17.85% from the prior year.
- Assets Average improved to $6.1 million in Q1 2026 per SXTP's latest filing, from $6.0 million in the prior quarter.
- Across five years, Assets Average topped out at $8.5 million in Q4 2023 and bottomed at $5.1 million in Q2 2025.
- Historically, Assets Average has averaged $6.6 million across 4 years, with a median of $6.1 million in 2026.
- Annual changes were most pronounced in 2024 — Assets Average declined 28.84% — and 2026, when it climbed 3.34%.
- 60 Degrees Pharmaceuticals' Assets Average stood at $8.5 million in 2023, then retreated by 22.17% to $6.6 million in 2024, then declined by 8.53% to $6.0 million in 2025, then increased by 0.61% to $6.1 million in 2026.
- Business Quant data shows SXTP's Assets Average at $6.1 million in Q1 2026, $6.0 million in Q4 2025, and $5.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | 5.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.06 Mn |
| Dec 31, 2025 | 6.03 Mn |
| Sep 30, 2025 | 5.44 Mn |
| Jun 30, 2025 | 5.08 Mn |
| Mar 31, 2025 | 5.87 Mn |
| Dec 31, 2024 | 6.59 Mn |
| Sep 30, 2024 | 5.87 Mn |
| Jun 30, 2024 | 6.35 Mn |
| Mar 31, 2024 | 8.08 Mn |
| Dec 31, 2023 | 8.47 Mn |
| Sep 30, 2023 | 8.25 Mn |